Quetiapine Fumarate Tablet
Product Images NDC 87441-072

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 87441-072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine 100 mg (8744107201 Quetiapine 100 mg)

Quetiapine Tablets USP 100 mg tablet label repackaged by Unit Dose Solutions, Inc. The label includes dosage instructions referencing prescribing information, medication guide dispensing instructions for pharmacists, storage conditions at 25°C with permitted excursions, and identification fields for lot, expiration, and quantity. Distributed by Tuckchee Enterprises, LLC.*

FDA Label Image

Molecular Structure (874e50ad 5da0 4ac3 9290 79442c91399e 01)

Chemical structure of quetiapine fumarate, showing the molecular arrangement of quetiapine and fumarate ions.*

FDA Label Image

Figure 1 (874e50ad 5da0 4ac3 9290 79442c91399e 02)

A Kaplan-Meier curve showing the proportion of patients with relapse over time in weeks for two groups: one treated with quetiapine fumarate plus lithium/valproate (QTP+LI/VAL, dashed line) and the other with placebo plus lithium/valproate (PLA+LI/VAL, solid line). The graph illustrates relapse rates increasing over a period up to 100 weeks.*

FDA Label Image

Figure 2 (874e50ad 5da0 4ac3 9290 79442c91399e 03)

A Kaplan-Meier curve graph showing the proportion of patients with relapse (%) over time in weeks (0 to 100). It compares two treatment groups labeled QTP+LI/VAL (dashed line) and PLA+LI/VAL (solid line). The graph illustrates relapse incidence increasing over time in both groups, with PLA+LI/VAL exhibiting a higher proportion of patients relapsing compared to QTP+LI/VAL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.